GlycoNex (4168)

Currency in TWD
23.10
+0.35(+1.54%)
Closed·
4168 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4168 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.8023.60
52 wk Range
15.6030.95
Key Statistics
Bid/Ask
33.25 / 33.30
Prev. Close
20.75
Open
22.85
Day's Range
22.8-23.6
52 wk Range
15.6-30.95
Volume
261.81K
Average Volume (3m)
518.16K
1-Year Change
-9.54%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4168 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

GlycoNex Company Profile

GlycoNex Incorporation engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. The company’s development pipeline for the treatment of solid tumors includes GNX102, a humanized monoclonal antibody, currently under phase 1 clinical stage; GNX201, an antibody drug currently under lead optimization stage; GNX202, an antibody drug currently under preclinical stage; and GNX203 and GNX204, antibody drugs currently under target validation stage. It is also involved in the development of SPD (Denosumab), a humanized IgG2 antibody that is in preclinical stage for the treatment of osteoporosis and oncology; and SEA (Aflibercept), a vascular endothelial growth factor binding fusion protein, currently under lead optimization stage for the treatment of ophthalmology and oncology. The company was incorporated in 2001 and is based in New Taipei City, Taiwan.

Compare 4168 to Peers and Sector

Metrics to compare
4168
Peers
Sector
Relationship
P/E Ratio
−12.2x−23.8x−0.5x
PEG Ratio
2.690.020.00
Price/Book
2.5x2.7x2.6x
Price / LTM Sales
129.3x29.4x3.3x
Upside (Analyst Target)
-0.0%42.8%
Fair Value Upside
Unlock−14.4%6.5%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.41 / --
Revenue / Forecast
13.57M / --
EPS Revisions
Last 90 days

4168 Income Statement

FAQ

What Stock Exchange Does GlycoNex Trade On?

GlycoNex is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for GlycoNex?

The stock symbol for GlycoNex is "4168."

What Is the GlycoNex Market Cap?

As of today, GlycoNex market cap is 2.46B.

What Is GlycoNex's Earnings Per Share (TTM)?

The GlycoNex EPS (TTM) is -1.86.

From a Technical Analysis Perspective, Is 4168 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has GlycoNex Stock Split?

GlycoNex has split 4 times.

How Many Employees Does GlycoNex Have?

GlycoNex has 0 employees.

What is the current trading status of GlycoNex (4168)?

As of 06 Aug 2025, GlycoNex (4168) is trading at a price of 23.10, with a previous close of 20.75. The stock has fluctuated within a day range of 22.80 to 23.60, while its 52-week range spans from 15.60 to 30.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.